DIFFERENTIAL DIAGNOSIS OF BRAIN GLIOMAS BY POSITRON EMISSION TOMOGRAPHY USING VARIOUS RADIOPHARMACEUTICALS

Objective: to comparatively study the diagnostic capabilities of positron emission tomography (PET) with various tumorotropic radiopharmaceuticals (TRPs) in detecting malignant brain gliomas (BG) and estimating their degree.

Material and methods. One hundred and fourteen patients, including 47 with histologically verified glioblastoma multiforme (GBM), 27 with anaplastic astrocytoma (AA), 23 with benign astrocytoma (BA), and 17 with postoperative cysts, were examined. PET was performed using TRPs: 18F-fluorodesoxyglucose (18F-FDG), 11C-sodium butyrate (11C-SB), 11C-L-methionine (11C-MET), and 11C-choline (11C-COL).

Results. Malignant gliomas (GBM and AA) were clearly visualized by PET using 11C-MET, 11C-CHOL, and 11C-SB. 18F-FDG PET visualization of tumors was difficult because of increased RP accumulation in the cerebral cortex. WHO grades II–III gliomas were completely visualized by 11C-MET PET. Only some tumors were clearly displayed by PET with 11C-CHOL and 11C-SB. The accumulation indices (AI) obtained by 11C-CHOL PET in patients with malignant gliomas were, on average, 4.0- and 5.5-fold higher than those by 11C-MET and 11C-SB PET, respectively. Significant differences (p<0.001) in AI obtained by 11C-CHOL (11C-CHOL-AI) PET were first established between the patients with GBM (WHO grade IV) and those with AA (WHO grade III).

Conclusion. 11C-CHOL PET is the most sensitive method to identify gliomas and estimate their grade. The advantage of 11C-MET PET is the possible imaging of the entire volume of viable tumor tissue.

1. Коновалов А.Н., Корниенко В.Н., Пронин И.И. Магнитно-резонансная томография в нейрохирургии. М.: Видар; 1997. Konovalov A.N., Kornienko V.N., Pronin I.I. Magnetic resonance tomography in neurosurgery. Мoscow: Vidar; 1997 (in Russian).

2. Granov А., Tiutin L., Schwartz T. et al. Positron emission tomography. Springer-Verlag-Heideberg; 2013.

3. Barker F.G., Chang S.M., Valk P.E., Pounds T.R., Prados M.D. 18Fluorodeoxyglucose uptake and survival of patients with suspected reccurent malignant glioma. Cancer. 1997; 1: 115–26.

4. De Witte O., Lefranc F., Levivier M. et al. FDG-PET as a prognostic factor in high-grade astrocytoma. J. Neurooncol. 2000; 49 (2): 157–63.

5. Костеников Н.А., Фадеев Н.П., Тютин Л.А., Зыков Е.М., Головцова М.Ю. Пятнадцатилетний опыт применения позитронной эмиссионной томографии с 11С-бутиратом натрия в нейроонкологии. Лучевая диагностика и терапия. 2012; 3 (4): 40–7. Kostenikov N.A., Fadeev N.P., Tyutin L.A., Zykov E.M., Golovtsova M.Yu. Fifteen years of experience on the use of positron emission tomography with 11C-sodium butyrate in neuro-oncology. Luchevaya diagnostika i terapiya. 2012; 3 (4): 40–7 (in Russian).

6. Padma M.V., Said S., Jacobs M. et al. Prediction of pathology and survival by FDG PET in gliomas. J. Neurooncol. 2003; 64 (3): 227–37.

7. Костеников Н.А., Фадеев Н.П., Тютин Л.А., Зыков Е.М., Панфиленко А.Ф., Головцова М.Ю., Илющенко Ю.Р. Сравнительное изучение особенностей визуализации глиальных опухолей при ПЭТ с различными туморотропными радиофармпрепаратами. Мед. визуализация. 2013; 2: 83–90. Kostenikov N.A., Fadeev N.P., Tyutin L.A., Zykov E.M., Panfilenko A.F., Golovtsova M.Yu., Ilyushchenko Yu.R. Comparative study of imaging features of glial tumors with different PET radiopharmaceuticals with tumor tropism. Meditsinskaya vizualizatsiya. 2013; 2: 83–90 (in Russian).

8. Kato T., Shinoda J., Nakayama N. et al. Metabolic assessment of gliomas using 11C-Methionine, [18F] Fluorodeoxyglucose, and 11C-Choline Positron-Emission Tomography. Am. J. Nucl. Radiol. 2008; 29: 1176–82.

9. Kracht L.W., Friese M., Herholtz K. et al. Methyl-[11C]-L-methionine uptake as measured by positrone emission tomography correlates to microvessel density in patients with glioma. Eur. J. Nucl. Med. Mol. Imag. 2003; 30 (6): 868–73.

10. Okubo S., Zhen H.N., Kawai N. et al. Correlation of L-methyl- 11C-methionine (MET) uptake with L-type amino acide transporter in human gliomas. J. Neurooncol. 2010; 99 (2): 217–25.

11. Скворцова Т.Ю., Рудас М.С., Бродская З.Л. и др. Новые критерии в позитронно-эмиссионнотомографической диагностике глиом головного мозга с использованием 11С-метионина. Вопросы нейрохир. 2001; 2: 12–6. Skvortsova T.Yu., Rudas M.S., Brodskaya Z.L. et al. New criteria for positron emission tomographydiagnosis of cerebral gliomas using 11C-methionine. Voprosy Neyrokhirurgii. 2001; 2: 12–6 (in Russian).

12. Tolvanen T., Yli-Kerttula T., Ujula T., Autio A., Lehikoinen P., Minn H., Roivainen A. Biodistribution and radiation dosimetry of [11C]choline a comparison between rat and human data. Eur. J. Nucl. Med. Mol. Imag. 2010; 37: 874–83.

13. Utrianen M., Komu M., Vuorinen V. et al. Evaluation of brain tumor metabolism with [11C] choline PET and 1H-MRS. J. Neurooncol. 2003; 62: 329–38.